Lavo Life Sciences Uptime Monitor
AI-Accelerated Chemistry Simulations for Rapid Drug Development
Last 30 Days Performance
Average Uptime
0%
Based on 30-day monitoring period
Average Response Time
0ms
Mean response time across all checks
Daily Status Overview
Hover for detailsHistorical Performance
Dec-2025
46.53% uptime
Monthly Uptime
46.53%
Monthly Response Time
69ms
Daily Status Breakdown
Nov-2025
98.7% uptime
Monthly Uptime
98.7%
Monthly Response Time
132ms
Daily Status Breakdown
Oct-2025
100% uptime
Monthly Uptime
100%
Monthly Response Time
135ms
Daily Status Breakdown
Sep-2025
100% uptime
Monthly Uptime
100%
Monthly Response Time
137ms
Daily Status Breakdown
Aug-2025
99.7% uptime
Monthly Uptime
99.7%
Monthly Response Time
137ms
Daily Status Breakdown
Jul-2025
99.87% uptime
Monthly Uptime
99.87%
Monthly Response Time
133ms
Daily Status Breakdown
Jun-2025
100% uptime
Monthly Uptime
100%
Monthly Response Time
148ms
Daily Status Breakdown
May-2025
100% uptime
Monthly Uptime
100%
Monthly Response Time
153ms
Daily Status Breakdown
Apr-2025
98.84% uptime
Monthly Uptime
98.84%
Monthly Response Time
178ms
Daily Status Breakdown
Related Uptime Monitors
Explore uptime status for similar tools that also have monitoring enabled.
-
OperationalPharma.ai
End-to-end generative AI software and automation platform for pharmaceutical research.
Pharma.ai is a commercially-available generative AI and automation platform designed to enhance the quality and productivity of pharmaceutical research.
Last checked: 2 hours ago View Status -
OperationalBenevolentAI
AI-Powered Drug Discovery and Development
BenevolentAI accelerates drug discovery by leveraging its proprietary AI platform, the Benevolent Platform™, to generate novel insights and increase the probability of clinical success.
Last checked: 2 hours ago View Status -
OperationalPhronesis AI
Autonomous Design of Small Molecule Therapeutics using Generative AI
Phronesis AI offers an autonomous AI drug design platform that creates and screens novel small molecules faster, cheaper, and with fewer failures through deep learning for therapeutic innovation.
Last checked: 2 hours ago View Status